Monica Fumagalli

Medicine & Life Sciences

1. Premature Infants 100%
2. Near-Infrared Spectroscopy 41%
3. Neonatal Intensive Care Units 36%
4. Newborn Infant 34%
5. Extremely Premature Infants 32%
6. Very Low Birth Weight Infant 26%
7. Parturition 26%
8. Mothers 26%
9. Brain 24%
10. Pregnancy 24%
11. Gestational Age 24%
12. Methylation 21%
13. Premature Birth 20%
14. Randomized Controlled Trials 16%
15. Child 16%
16. Hemorrhage 16%
17. Magnetic Resonance Imaging 15%
18. Brain Injuries 15%
19. Guidelines 13%
20. Psychological Distress 13%
21. Therapeutics 13%
22. Oximetry 13%
23. Precursor Cell Lymphoblastic Leukemia-Lymphoma 12%
24. Brain Hypoxia 12%
25. Oxygen 11%
26. Pain 11%
27. CH5424802 11%
28. Acute Myeloid Leukemia 10%
29. Cerebrovascular Circulation 10%
30. Phase II Clinical Trials 10%
31. Ibuprofen 10%
32. Drug Therapy 10%
33. Child Development 9%
34. White Matter 9%
35. Serotonin Plasma Membrane Transport Proteins 9%
36. Extremely Low Birth Weight Infant 9%
37. Patent Ductus Arteriosus 9%
38. Fetal Development 9%
39. Neonatologists 9%
40. Consensus 9%
41. Fetus 9%
42. Equipment and Supplies 8%
43. Systematic Reviews 8%
44. Bronchopulmonary Dysplasia 8%
45. Retinopathy of Prematurity 8%
46. Seizures 7%
47. Epigenomics 7%
48. Hyperoxia 7%
49. Observational Studies 7%
50. Infantile Epileptic-Dyskinetic Encephalopathy 7%